Form 4: Intellia Therapeutics Executive Sells Shares
Insider Transaction (Form 4)
Michael P Dube, VP, Chief Accounting Officer of Intellia Therapeutics, Inc., sold 1,864 shares of common stock on October 2, 2026 for $12.43 per share.
Summary
- Open-market sale: disposed of 1,864 Common Stock at $12.43 ($23,170) on October 2, 2026; holds 65,022 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $23,170 of stock on the open market.
Insider Transactions
Michael P Dube — Officer (VP, Chief Accounting Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-02 | Open-market sale | Common Stock | 1,864 | $12 | $23.2K | 65,022 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-02 | Open-market sale (1,864 shares) |
Keywords
insider transaction, Form 4, NTLA, Intellia Therapeutics, Inc., bearish, Michael P Dube
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.